Strategy Inc - Medical Device - Lifescience Business Consulting

Strategy Inc., www.strategyinc.net, a global lifescience business intelligence company, offers a full suite of strategic medical device business consulting services for financial and market due diligence. Our deliverables combine rigorous analysis with decades of industry knowledge. Determining the value of innovation drives prioritization of resources, captures investment at the highest value and focuses on the indication with the highest probability for successful commercialization. Our clients include enterprise companies, financiers and emerging companies with technologies in all stages of the product lifecycle. Strategy Inc. performs market analyses, commercialization strategies and voice of the customer analyses to validate market need, projected adoption and purchasing patterns to ensure successful commercialization of emerging technology. Services include: • Market Analysis • Voice of the Customer Analysis • Value Analysis Strategy • KOL Identification and Validation • Competitive Strategy (competitive landscape and positioning analysis) • Financial Valuation • Exit Strategy • Tech Select Please contact us at info@strategyinc.net to learn more about these services and others. Founded in 2000, Strategy Inc. is located in Austin, Texas, Research Triangle, North Carolina and Los Angeles, California. Approximately 88% of the lifescience entities that seek the services of Strategy Inc. are involved in emerging, medical technologies that are changing the standard of care. Clients include medical device and biotech companies, venture capital and private equity firms considering investments, law firms specializing in emerging biomedical technology and regional and university-based incubator/accelerators. Clients are located in the US, France, Germany, UK, Spain, Israel, China, and South America.